Used in research for its potential as a selective inhibitor of p38 MAP kinase, a pathway involved in inflammation and cancer. It has been studied for its ability to modulate cellular responses in tumor models, particularly in combination with other anticancer agents to enhance efficacy. Its application is primarily in preclinical studies to understand signaling pathways and to develop targeted therapies for inflammatory diseases and oncology.